Clinician's dilemma: Naproxen-induced liver injury

Indian J Pathol Microbiol. 2023 Jan-Mar;66(1):168-170. doi: 10.4103/ijpm.ijpm_766_21.

Abstract

Naproxen is a widely used nonsteroidal anti-inflammatory drug (NSAID) in pediatric population, used for mild-to-moderate pains, arthritis, and other immune-mediated disorders. It rarely causes clinically apparent liver injury in the adult population taking high doses of the drug over a prolonged period and is reported even rarer in pediatric population. We present a case of drug-induced liver injury (DILI) in a 13-year-old girl taking naproxen in therapeutic doses for juvenile rheumatoid arthritis. There was a complete recovery of liver function following discontinuation of naproxen therapy.

Keywords: DILI; drug-induced liver injury; juvenile rheumatoid arthritis; naproxen; nonsteroidal anti-inflammatory drug.

Publication types

  • Case Reports

MeSH terms

  • Adolescent
  • Adult
  • Anti-Inflammatory Agents, Non-Steroidal / adverse effects
  • Arthritis, Juvenile* / drug therapy
  • Chemical and Drug Induced Liver Injury, Chronic* / drug therapy
  • Child
  • Female
  • Humans
  • Naproxen / adverse effects

Substances

  • Naproxen
  • Anti-Inflammatory Agents, Non-Steroidal